33938 Federal Register / Vol. 61, No. 127 / Monday, July 1, 1996 / Notices

Purpose/Agenda: To review and evaluate

cooperative agreement grant applications.

These meetings will be closed in

accordance with the provisions set forth in

sections 552b(c)(4) and 552b(c)(6), Title 5,

U.S.C. Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.837, Heart and Vascular

Diseases Research; 93.838, Lung Diseases

Research; and 93.839, Blood Diseases and

Resources Research, National Institutes of

Health)

Dated: June 24, 1996.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 96–16717 Filed 6–28–96; 8:45 am]

BILLING CODE 4140–01–M

National Heart, Lung, and Blood

Institute; Notice of Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following Heart,

Lung, and Blood Special Emphasis

Panel (SEP) meetings:

Name of SEP: Pathways—Full Scale Study

(Telephone Conference Call).

Date: July 18, 1996.

Time: 10:00 a.m.

Place: Two Rockledge Center, 6701

Rockledge Drive, Rm. 7220, Bethesda,

Maryland 20892.

Contact Person: C. James Scheirer, Ph.D.,

Two Rockledge Center, Room 7220, 6701

Rockledge Drive, Bethesda, MD 20892–7924,

(301) 435–0266.

Purpose/Agenda: To review and evaluate

grant applications.

This notice is being published less

than fifteen days prior to this meeting

due to the urgent need to meet timing

limitations imposed by the review and

funding cycle.

Name of SEP: Regulation of Human

Immunodeficiency Virus in the Lung.

Date: July 22–23, 1996.

Time: 8:00 a.m.

Place: Holiday Inn Bethesda, 8120

Wisconsin Avenue, Bethesda, Maryland

20814.

Contact Person: Deborah P. Beebe, Ph.D.,

Two Rockledge Center, Room 7206, 6701

Rockledge Drive, Bethesda, MD 20892–7924,

(301) 435–0303.

Purpose/Agenda: To review and evaluate

grant applications.

These meetings will be closed in

accordance with the provisions set forth in

sections 552b(c)(4) and 552b(c)(6), Title 5,

U.S.C. Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.837, Heart and Vascular

Diseases Research; 93.838, Lung Diseases

Research; and 93.839, Blood Diseases and

Resources Research, National Institutes of

Health)

Dated: June 24, 1996.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 96–16718 Filed 6–28–96; 8:45 am]

BILLING CODE 4140–01–M

National Institute of Allergy and

Infectious Diseases; Notice of Closed

Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute of Allergy and

Infectious Diseases Special Emphasis

Panel (SEP) meeting:

Name of SEP: Master Agreement for HIV

Preclinical Vaccine Development Category B:

Evaluation of AIDS Vaccines in Non-Human

Primates (Telephone Conference Call).

Date: July 3, 1996.

Time: 12:00 p.m.

Place: Telephone Conference Call, 6003

Executive Blvd., Solar Bldg., Room 4C03,

Bethesda, MD 20892–7610, (301) 402–4596.

Contact Person: Dr. Christopher E. Beisel,

Scientific Review Adm., 6003 Executive

Boulevard, Solar Bldg., Room 4C03,

Bethesda, MD 20892–7610, (301) 402–4596.

Purpose/Agenda: To evaluate contract

proposals.

The meeting will be closed in accordance

with the provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

This notice is being published less

than 15 days prior to the meeting due

to the urgent need to meet timing

limitations imposed by the review and

funding cycle.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.855, Immunology, Allergic

and Immunologic Diseases Research; 93.856,

Microbiology and Infectious Diseases

Research, National Institutes of Health)

Dated: June 24, 1996.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 96–16719 Filed 6–28–96; 8:45 am]

BILLING CODE 4140–01–M

Division of Research Grants; Notice of

Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following Division

of Research Grants Special Emphasis

Panel (SEP) meetings:

Purpose/Agenda: To review individual

grant applications.

Name of SEP: Clinical Sciences.

Date: July 10, 1996.

Time: 3:00 p.m.

Place: NIH, Rockledge 2, Room 4126,

Telephone Conference.

Contact Person: Dr. Jerrold Fried, Scientific

Review Administrator, 6701 Rockledge Drive,

Room 4126, Bethesda, Maryland 20892, (301)

435–1777.

Name of SEP: Biological and Physiological

Sciences.

Date: July 15, 1996.

Time: 1:00 p.m.

Place: NIH, Rockledge 2, Room 5122,

Telephone Conference.

Contact Person: Dr. Michael Lang,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5122, Bethesda,

Maryland 20892, (301) 435–1265.

Name of SEP: Biological and Physiological

Sciences.

Date: July 16, 1996.

Time: 1:00 p.m.

Place: NIH, Rockledge 2, Room 5122,

Telephone Conference.

Contact Person: Dr. Michael Lang,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5122, Bethesda,

Maryland 20892, (301) 435–1265.

Name of SEP: Biological and Physiological

Sciences.

Date: July 17, 1996.

Time: 1:00 p.m.

Place: NIH, Rockledge 2, Room 5122,

Telephone Conference.

Contact Person: Dr. Michael Lang,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5122, Bethesda,

Maryland 20892, (301) 435–1265.

Name of SEP: Multidisciplinary Sciences.

Date: July 17, 1996.

Time: 1:00 p.m.

Place: NIH, Rockledge 2, Room 5208,

Telephone Conference.

Contact Person: Dr. Houston Baker,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5208, Bethesda,

Maryland 20892, (301) 435–1175.

This notice is being published less

than 15 days prior to the above meetings

due to the urgent need to meet timing

limitations imposed by the review and

funding cycle.

Name of SEP: Biological and Physiological

Sciences.

Date: July 18, 1996.

Time: 9:00 a.m.

Place: One Washington Circle Hotel,

Washington, DC.

Contact Person: Dr. Anita Sostek, Scientific

Review Administrator, 6701 Rockledge Drive,
Federal Register / Vol. 61, No. 127 / Monday, July 1, 1996 / Notices 33939

Room 5202, Bethesda, Maryland 20892, (301)

435–1260.

Name of SEP: Microbiological and

Immunological Sciences.

Date: July 23, 1996.

Time: 10:00 a.m.

Place: NIH, Rockledge 2, Room 4180,

Telephone Conference.

Contact Person: Dr. Tim Henry, Scientific

Review Administrator, 6701 Rockledge Drive,

Room 4180, Bethesda, Maryland 20892, (301)

435–1147.

Name of SEP: Microbiological and

Immunological Sciences.

Date: July 23, 1996.

Time: 1:00 p.m.

Place: NIH, Rockledge 2, Room 4180,

Telephone Conference.

Contact Person: Dr. Tim Henry, Scientific

Review Administrator, 6701 Rockledge Drive,

Room 4180, Bethesda, Maryland 20892, (301)

435–1147.

Name of SEP: Biological and Physiological

Sciences.

Date: July 24, 1996.

Time: 3:00 p.m.

Place: NIH, Rockledge 2, Room 5196,

Telephone Conference.

Contact Person: Ms. Carol Campbell,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5196, Bethesda,

Maryland 20892, (301) 435–1257.

Name of SEP: Microbiological and

Immunological Sciences.

Date: July 24, 1996.

Time: 10:00 a.m.

Place: NIH, Rockledge 2, Room 4180,

Telephone Conference.

Contact Person: Dr. Tim Henry, Scientific

Review Administrator, 6701 Rockledge Drive,

Room 4180, Bethesda, Maryland 20892, (301)

435–1147.

Name of SEP: Microbiological and

Immunological Sciences.

Date: July 24, 1996.

Time: 1:00 p.m.

Place: NIH, Rockledge 2, Room 4180,

Telephone Conference.

Contact Person: Dr. Tim Henry, Scientific

Review Administrator, 6701 Rockledge Drive,

Room 4180, Bethesda, Maryland 20892, (301)

435–1147.

Name of SEP: Microbiological and

Immunological Sciences.

Date: July 25, 1996.

Time: 10:00 a.m.

Place: NIH, Rockledge 2, Room 4180,

Telephone Conference.

Contact Person: Dr. Tim Henry, Scientific

Review Administrator, 6701 Rockledge Drive,

Room 4180, Bethesda, Maryland 20892, (301)

435–1147.

Name of SEP: Microbiological and

Immunological Sciences.

Date: July 25, 1996.

Time: 1:00 p.m.

Place: NIH, Rockledge 2, Room 4180,

Telephone Conference.

Contact Person: Dr. Tim Henry, Scientific

Review Administrator, 6701 Rockledge Drive,

Room 4180, Bethesda, Maryland 20892, (301)

435–1147.

Purpose/Agenda: To review Small

Business Innovation Research.

Name of SEP: Biological and Physiological

Sciences.

Date: July 18–19, 1996.

Time: 11:00 a.m.

Place: One Washington Circle Hotel,

Washington, DC.

Contact Person: Dr. Anita Sostek, Scientific

Review Administrator, 6701 Rockledge Drive,

Room 5202, Bethesda, Maryland 20892, (301)

435–1260.

Name of SEP: Microbiological and

Immunological Sciences.

Date: July 24–26, 1996.

Time: 8:30 a.m.

Place: Holiday Inn, Chevy Chase, MD.

Contact Person: Dr. Martin Slater,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4184, Bethesda,

Maryland 20892, (301) 435–1149.

The meetings will be closed in accordance

with the provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program Nos. 93.306, 93.333, 93.337, 93.393–

93.396, 93.837–93.844, 93.846–93.878,

93.892, 93.893, National Institutes of Health,

HHS)

Dated: June 24, 1996.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 96–16714 Filed 6–28–96; 8:45 am]

BILLING CODE 4140–01–M

Division of Research Grants; Notice of

Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following Division

of Research Grants Special Emphasis

Panel (SEP) meetings:

Purpose/Agenda: To review individual

grant applications.

Name of SEP: Biological and Physiological

Sciences.

Date: July 19, 1996.

Time: 2:00 p.m.

Place: NIH, Rockledge 2, Room 5196,

Telephone Conference.

Contact Person: Ms. Carol Campbell,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5196, Bethesda,

Maryland 20892, (301) 435–1257.

Name of SEP: Biological and Physiological

Sciences.

Date: July 30, 1996.

Time: 11:30 a.m.

Place: NIH, Rockledge 2, Room 4150,

Telephone Conference.

Contact Person: Dr. Marcia Litwack,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4150, Bethesda,

Maryland 20892, (301) 435–1719.

Name of SEP: Biological and Physiological

Sciences.

Date: July 31, 1996.

Time: 2:00 p.m.

Place: NIH, Rockledge 2, Room 4150,

Telephone Conference.

Contact Person: Dr. Marcia Litwack,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4150, Bethesda,

Maryland 20892, (301) 435–1719.

The meetings will be closed in accordance

with the provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program Nos. 93.306, 93.333, 93.337, 93.393–

93.396, 93.837–93.844, 93.846–93.878,

93.892, 93.893, National Institutes of Health,

HHS)

Dated: June 24, 1996.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 96–16716 Filed 6–28–96; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HOUSING AND

URBAN DEVELOPMENT

[Docket No. FR–3960–N–05]

Office of the Assistant Secretary for

Policy Development and Research;

Announcement of Funding Award for

the Education Component of the

Community Renaissance Fellows

Program (CRFP)

AGENCY: Office of the Assistant

Secretary for Policy Development and

Research, HUD.

ACTION: Announcement of funding

award.

SUMMARY: In accordance with section

102(a)(4)(C) of the Department of

Housing and Urban Development

Reform Act of 1989, this document

notifies the public of the funding award

for the education component of the

Community Renaissance Fellows

Program. This award will be used to

develop and offer an education

component as part of the Department’s

new Community Renaissance Fellows

Program. Under this program, HUD will

create fellowships to foster a cadre of

community building professionals who

apply the practical experience gained in

working on public housing

transformation projects and apply this

knowledge to other complex

neighborhood revitalization projects.

The purpose of this document is to